Ledger.Open graph →
SEC Form D · filed February 2, 2016

Agilis Biotherapeutics, LLC

Offering
$5.0M
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

G. H. Hall · Dallas, TXDirectorAdrian Z. Stecyk · Dallas, TXDirectorMark J. Pykett · Cambridge, MADirectorArthur J. Tzianabos · Cambridge, MADirectorAlexander M. Seaver · Dallas, TXDirectorAlexander M. Seaver · Dallas, TXDirectorG. H. Hall · Dallas, TXDirectorAdrian Z. Stecyk · Dallas, TXDirectorMark J. Pykett · Cambridge, MADirectorArthur J. Tzianabos · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗